Oral Abstract Session:
114. Hepatitis C: Epidemiology and Elimination
Friday, October 5, 2018: 8:45 AM-10:00 AM
Room: W 2002

Tracks: Adult ID, Epidemiology and Infection Control, Investigative ID, Pediatric ID

Moderators:  Susanna Naggie, MD, MHS, Duke University Medical Center, Duke Clinical Research Institute and Dawd Siraj, MD, MPH&TM, University of Wisconsin-Madison

8:45 AM
Major Decrease in Prevalence of Hepatitis C Viremia in Key Populations following the 2nd Year of Treatment as Prevention for Hepatitis C (TraP HepC) Program in Iceland
Magnus Gottfredsson, MD, PhD; Thorarinn Tyrfingsson, MD; Valgerdur Runarsdottir, MD; Ingunn Hansdottir, PhD; Ottar M. Bergmann, MD; Einar S. Bjornsson, MD, PhD; Birgir Johannsson, MD; Bryndis Sigurdardottir, MD; Ragnheidur H. Fridriksdottir, RN, MBA; Arthur Löve, MD, PhD; Thorvardur J. Löve, MD, PhD; Gudrun Sigmundsdottir, MD, PhD; Ubaldo Hernandez, MSc; Maria Heimisdottir, MD, PhD, MBA; Sigurdur Olafsson, MD
9:00 AM
HCV Treatment is Associated with a Reduced Risk of Cardiovascular Disease Events: Results from ERCHIVES
Adeel Ajwad Butt, Professor of Medicine/Professor of Healthcare Policy and Research; Peng Yan, MS; Ashfaq Shuaib, MD; Abdul-Badi Abou-Samra, MD, PhD; Obaid Saikh, MD; Matthew Freiberg, MD, MSc
9:15 AM
Telemedicine for the Treatment of Hepatitis C: A Systematic Review and Meta-Analysis
David De Gijsel, MD, MSc; Blake Kruger, BS; Dema Hakim, BS; Sarah Moore, BA
9:30 AM
Universal Hepatitis C Virus Screening in a Tennessee Tertiary Care Emergency Department
Cody A. Chastain, MD; Jakea Johnson, MPH; Karen Miller, RN, MPA, CHFN; Katie Moore, BSN, RN, CCRN; Amanda Lako, BSN, RN, CEN; Autumn Zuckerman, PharmD, BCPS, AAHIVP, CSP; Jin H. Han, MD, MSc; Wesley H. Self, MD, MPH

CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.